** Shares of Telix Pharmaceuticals TLX.AX rise 2.9% to A$25.52, on track for best day since June 4

** TLX among top gainers on the benchmark index .AXJO

** The biopharma co announced on Friday after market hours that its prostate cancer imaging agent Illuccix was granted marketing authorization by the National Organization for Medicines $(EOF.AU)$ of Greece

** Stock up 3.6% YTD, including moves in current session

(Reporting by Jasmeen Ara Shaikh in Bengaluru)

((JasmeenAraIslam.Shaikh@thomsonreuters.com;))